1. Home
  2. KEQU vs IPHA Comparison

KEQU vs IPHA Comparison

Compare KEQU & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEQU
  • IPHA
  • Stock Information
  • Founded
  • KEQU 1906
  • IPHA 1999
  • Country
  • KEQU United States
  • IPHA France
  • Employees
  • KEQU N/A
  • IPHA N/A
  • Industry
  • KEQU Medical Specialities
  • IPHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KEQU Industrials
  • IPHA Health Care
  • Exchange
  • KEQU Nasdaq
  • IPHA Nasdaq
  • Market Cap
  • KEQU 183.3M
  • IPHA 148.3M
  • IPO Year
  • KEQU N/A
  • IPHA 2019
  • Fundamental
  • Price
  • KEQU $62.00
  • IPHA $1.69
  • Analyst Decision
  • KEQU
  • IPHA Strong Buy
  • Analyst Count
  • KEQU 0
  • IPHA 1
  • Target Price
  • KEQU N/A
  • IPHA $11.50
  • AVG Volume (30 Days)
  • KEQU 33.0K
  • IPHA 59.0K
  • Earning Date
  • KEQU 03-05-2025
  • IPHA 09-12-2024
  • Dividend Yield
  • KEQU N/A
  • IPHA N/A
  • EPS Growth
  • KEQU 168.79
  • IPHA N/A
  • EPS
  • KEQU 6.31
  • IPHA N/A
  • Revenue
  • KEQU $199,637,000.00
  • IPHA $36,202,722.00
  • Revenue This Year
  • KEQU N/A
  • IPHA N/A
  • Revenue Next Year
  • KEQU N/A
  • IPHA $101.65
  • P/E Ratio
  • KEQU $9.60
  • IPHA N/A
  • Revenue Growth
  • KEQU N/A
  • IPHA N/A
  • 52 Week Low
  • KEQU $27.00
  • IPHA $1.29
  • 52 Week High
  • KEQU $67.20
  • IPHA $3.51
  • Technical
  • Relative Strength Index (RSI)
  • KEQU 63.56
  • IPHA 42.95
  • Support Level
  • KEQU $54.02
  • IPHA $1.60
  • Resistance Level
  • KEQU $62.63
  • IPHA $1.87
  • Average True Range (ATR)
  • KEQU 3.47
  • IPHA 0.13
  • MACD
  • KEQU -0.77
  • IPHA -0.04
  • Stochastic Oscillator
  • KEQU 60.55
  • IPHA 16.67

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: